Palo Alto Investors LP Evolus, Inc. Transaction History
Palo Alto Investors LP
- $856 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding EOLS
# of Institutions
173Shares Held
47MCall Options Held
720KPut Options Held
532K-
Perceptive Advisors LLC New York, NY5.75MShares$62.4 Million1.69% of portfolio
-
Tang Capital Management LLC San Diego, CA4.15MShares$45 Million7.07% of portfolio
-
Black Rock Inc. New York, NY3.26MShares$35.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.04MShares$33 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.91MShares$31.6 Million2.62% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $609M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...